By regulating downstream signaling pathways, mainly PI3K/Akt and MAPK pathways, the activated EGFR leads to receptor dimerization and tyrosine autophosphorylation, which could result in aberrant proliferation in certain cells, such as NSCLC cells. This evidence concerns the gene EGFR and non-small cell lung carcinoma.